PlexBio Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Dean Tsao

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	4.1%
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

PlexBio (GTSM:6572) Shareholders Have Enjoyed A 11% Share Price Gain

Feb 16

We Think PlexBio (GTSM:6572) Can Afford To Drive Business Growth

Dec 22

CEO

Dean Tsao

no data

Tenure

Dr. Dean Tsao, PhD serves as the Chairman, President and Chief Executive Officer of PlexBio Co. Ltd. Dr. Tsao serves as the Chief Executive Officer and Chairman of Genemed Biotechnologies, Inc. Dr. Tsao is...

PlexBio Management

Management criteria checks 0/4

Key information

Recent management updates

PlexBio Co., Ltd., Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

PlexBio Co., Ltd., Annual General Meeting, Jun 23, 2022

Recent updates

Full year 2023 earnings released: NT$0.56 loss per share (vs NT$0.51 loss in FY 2022)

PlexBio Co., Ltd., Annual General Meeting, Jun 18, 2024

New minor risk - Financial data availability

New minor risk - Share price stability

Less than half of directors are independent

First half 2022 earnings released: EPS: NT$0 (vs NT$0.57 loss in 1H 2021)

Full year 2021 earnings released: NT$1.27 loss per share (vs NT$1.37 loss in FY 2020)

Less than half of directors are independent

PlexBio Co., Ltd., Annual General Meeting, Jun 23, 2022

Full year 2020 earnings released: NT$1.37 loss per share (vs NT$2.32 loss in FY 2019)

New 90-day low: NT$20.10

PlexBio (GTSM:6572) Shareholders Have Enjoyed A 11% Share Price Gain

We Think PlexBio (GTSM:6572) Can Afford To Drive Business Growth

New 90-day low: NT$20.45

New 90-day low: NT$25.40

New 90-day low: NT$28.55

New 90-day low: NT$37.45

New 90-day low - NT$41.95

First half earnings released

CEO

Tenure